ESLA
Estrella Immunopharma, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 1:49:47 PM EST
0.35USD+4.386%(+0.01)217,114
Pre-marketNov 19, 2026 9:07:30 AM EST
0.333USD+0.030%(+0.00)
ESLA Financials
In Q3 FY 2026 (ended ), Estrella Immunopharma, Inc. Common Stock (ESLA) reported net income of −$7.38M, operating cash flow of −$217.21K, and assets of $1.67M (filed ).
Loading financial statements…